Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nauman A. Khan, Keerat A. Ahuja, Xiaofeng Wang & Neal F. Chaisson. (2021) Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension. Leukemia & Lymphoma 62:6, pages 1458-1465.
Read now
Read now
Safia Chebrek, Karim Aïssi, Yves Francès, Cédric Mercier, Laure Farnault, Gérard Sébahoun & Régis Costello. (2014) Pulmonary hypertension in patients with chronic myeloproliferative neoplasms. Leukemia & Lymphoma 55:1, pages 223-225.
Read now
Read now
Rajiv S. Swamy & John P. Kress. (2007) Pulmonary arterial hypertension and myeloproliferative disorders. Leukemia & Lymphoma 48:10, pages 1891-1893.
Read now
Read now
Articles from other publishers (28)
David Montani, Pierre Thoré, Xavier Mignard, Xavier Jaïs, Athénaïs Boucly, Mitja Jevnikar, Andrei Seferian, Etienne-Marie Jutant, Vincent Cottin, Elie Fadel, Gérald Simonneau, Laurent Savale, Olivier Sitbon & Marc Humbert. (2023) Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study. American Journal of Respiratory and Critical Care Medicine 208:5, pages 600-612.
Crossref
Crossref
Mazen Al-Qadi, Barbara LeVarge & H. James Ford. (2021) Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension. Frontiers in Medicine 7.
Crossref
Crossref
Alberto Ferrari, Joseph Scandura, Arianna Masciulli, Spencer Krichevsky, Antonello Gavazzi & Tiziano Barbui. (2020) Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms. European Journal of Haematology 106:2, pages 250-259.
Crossref
Crossref
Kadriye Bahriye Payzin, Kaan Savasoglu, Inci Alacacioglu, Elif Ebru Dalgic, Betul Bolat Kucukzeybek, Aylin Orgen Calli, Sadi Bener & Serdar Payzin. (2021) BCR-ABL1–Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival. Clinical Lymphoma Myeloma and Leukemia 21:2, pages 125-131.
Crossref
Crossref
Yanika Jindamai, Ekarat Rattarittamrong, Arintaya Phrommintikul, Lalita Yongsmith, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit & Lalita Norasetthada. (2020) Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients. International Journal of Hematology 112:5, pages 631-639.
Crossref
Crossref
Myeong-Won Lee, Hyewon Ryu, Yoon-Seok Choi, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Byung Joo Sun, Jin-Ok Jeong & Deog-Yeon Jo. (2020) Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients. BLOOD RESEARCH 55:2, pages 77-84.
Crossref
Crossref
Rohan Gupta, Faizi Jamal, Dongyun Yang, Chendri Chendri, Ibrahim Aldoss, Monzr Al Malki, Matthew Mei, Amandeep Salhotra, Surime Dobrin, Michael Tran, K. Venkataraman, Joycelynne Palmer, Anthony S. Stein, Karamjeet Sandhu, Samer Khaled, Ahmed Aribi, Guido Marcucci, Stephen J. Forman, David Snyder, Ryotaro Nakamura, Haris Ali & Vinod Pullarkat. (2019) Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis. Bone Marrow Transplantation 55:5, pages 877-883.
Crossref
Crossref
Kasper Mønsted Pedersen, Yunus Çolak, Hans Carl Hasselbalch, Christina Ellervik, Børge Grønne Nordestgaard & Stig Egil Bojesen. (2020) Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study. EClinicalMedicine 21, pages 100295.
Crossref
Crossref
Juan Lopez-Mattei, Srdan Verstovsek, Bryan Fellman, Cezar Iliescu, Karan Bhatti, Saamir A. Hassan, Peter Kim, Brian A. Gray, Nicolas L. Palaskas, Horiana B. Grosu, Mamas A. Mamas & Saadia A. Faiz. (2020) Prevalence of pulmonary hypertension in myelofibrosis. Annals of Hematology 99:4, pages 781-789.
Crossref
Crossref
Jiwon Kim, Spencer Krichevsky, Lola Xie, Maria Chiara Palumbo, Sara Rodriguez-Diego, Brian Yum, Lillian Brouwer, Richard T. Silver, Andrew I. Schafer, Ellen K. Ritchie, Maria Mia Yabut, Claudia Sosner, Evelyn M. Horn, Richard B. Devereux, Joseph M. Scandura & Jonathan W. Weinsaft. (2019) Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm–Associated Pulmonary Hypertension. Journal of the American Society of Echocardiography 32:12, pages 1574-1585.
Crossref
Crossref
Geoffroy Venton, Mihai Turcanu, Julien Colle, Franck Thuny, Safia Chebrek, Laure Farnault, Cédric Mercier, Vadim Ivanov, Raphaëlle Fanciullino, Pierre Suchon, Pierre-André Jarrot, Karim Aissi, Pauline Roche, Jennifer Cautela, Robin Arcani & Regis Costello. (2019) Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients. European Journal of Internal Medicine 68, pages 71-75.
Crossref
Crossref
Mette Brabrand, Knud Nørregaard Hansen, Christian B. Laursen, Thomas Stauffer Larsen, Hanne Vestergaard & Niels Abildgaard. (2019) Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms. European Journal of Haematology 102:3, pages 227-234.
Crossref
Crossref
Tieci Yi, Wei Ma, Jianxing QiuWenhui Ding. (2019) Pulmonary hypertension with massive megalosplenia. Medicine 98:12, pages e14594.
Crossref
Crossref
Jason Weatherald, Laurent Savale & Marc Humbert. (2017) Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?. Current Hypertension Reports 19:11.
Crossref
Crossref
Takayoshi Tachibana, Naoki Nakayama, Ayako Matsumura, Yuki Nakajima, Hiroyuki Takahashi, Takuya Miyazaki & Hideaki Nakajima. (2017) Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera. Internal Medicine 56:18, pages 2487-2492.
Crossref
Crossref
Matthew Jankowich, Beth Elston, Samuel K. Evans, Wen-Chih Wu & Gaurav Choudhary. (2016) Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study. PLOS ONE 11:12, pages e0167987.
Crossref
Crossref
Mervat M. Mattar, Mohammed Abdel Kader Morad, Noha M. El Husseiny, Noha H. Ali & Doaa M. El Demerdash. (2016) Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience. Annals of Hematology 95:10, pages 1611-1616.
Crossref
Crossref
Simona Raso, Mariasanta Napolitano, Giorgia Saccullo & Sergio Siragusa. (2016) Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia. Annals of Hematology 95:8, pages 1389-1390.
Crossref
Crossref
Tomasz Sacha, Sebastian Szmit, Dorota Zozulińska-Ziółkiewicz, Witold Prejzner & Joanna Góra-Tybor. (2016) Zalecenia dotyczące oceny schorzeń współistniejących u chorych na przewlekłą białaczkę szpikową w procesie wyboru inhibitora kinaz tyrozynowych. Acta Haematologica Polonica 47:3, pages 184-196.
Crossref
Crossref
Gaurav Choudhary & Corey E. Ventetuolo. 2016. Pulmonary Hypertension. Pulmonary Hypertension
63
79
.
Yochai Adir, Davide Elia & Sergio Harari. (2015) Pulmonary hypertension in patients with chronic myeloproliferative disorders. European Respiratory Review 24:137, pages 400-410.
Crossref
Crossref
Sapna Bhatia, Frederick Melendres & Lana Melendres-Groves. (2015) Pulmonary Hypertension in Chronic Myeloproliferative Disorders. Advances in Pulmonary Hypertension 14:3, pages 150-154.
Crossref
Crossref
Roberto F. Machado & Harrison W. Farber. (2013) Pulmonary Hypertension Associated with Chronic Hemolytic Anemia and Other Blood Disorders. Clinics in Chest Medicine 34:4, pages 739-752.
Crossref
Crossref
Tim Lahm & Murali M. Chakinala. (2013) World Health Organization Group 5 Pulmonary Hypertension. Clinics in Chest Medicine 34:4, pages 753-778.
Crossref
Crossref
R. Costello, C. Sanchez, L. Farnault, C. Mercier, V. Bergoin, T. Le Treut & G. Sébahoun. (2013) Thrombocythémie essentielle. EMC - Hématologie 8:2, pages 1-11.
Crossref
Crossref
Judd W. Landsberg & Jess Mandel. 2011. Textbook of Pulmonary Vascular Disease. Textbook of Pulmonary Vascular Disease
1061
1081
.
R. Costello. (2010) Hypertension artérielle pulmonaire et hémopathies malignes. La Revue de Médecine Interne 31:9, pages 621-625.
Crossref
Crossref
Walid Rasheed, Brendan Flaim & John F. Seymour. (2009) Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia. Leukemia Research 33:6, pages 861-864.
Crossref
Crossref